|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/12 | |||
| A61K 39/145 |
| (11) | Number of the document | 2364721 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11168821.4 |
| Date of filing the European patent application | 2006-12-12 | |
| (97) | Date of publication of the European application | 2011-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0525321 | 2005-12-13 | GB | |
| 0609902 | 2006-05-18 | GB | |
| 0620336 | 2006-10-12 | GB | |
| 0620337 | 2006-10-12 | GB |
| (72) |
Vandepapeliere, Pierre, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | Vaccine compositions comprising a saponin adjuvant |
| Vaccine compositions comprising a saponin adjuvant |